We aimed to investigate the prevalence of cardiometabolic (CM) risk factors(impaired fasting glucose (>100 mg/dL), high blood pressure, overweight orobesity, high serum triglycerides (TG) and low serum high-density lipoproteincholesterol levels) in children with hepatosteatosis detected by abdominalultrasound. Children whom ultrasound examination revealed hepatic steatosiswere included in the study. Medical records, anthropometric and biochemicalparameters were reviewed for the presence of the CM risk factors. Presence of≥3 risk factors was defined as metabolic syndrome (MS).One hundred and forty-eight children and adolescents (67 boys, 81girls, andmean age 12.1±2.7 years) with hepatosteatosis were included. Sonographichepatosteatosis grades of 1, 2 and 3 were observed in 111 (75%), 33 (22.3%),and 4 (2.7%) subjects, respectively. MS was observed in 36 patients (24.3%).The number of CM risk factors and degree of hepatic steatosis were correlated(r=0.183, p=0.026). Serum TG levels in girls and age in boys were significantlyassociated with the presence of medium to severe hepatosteatosis (grades 2 or3) (R2=.342, =.040 and R2=.538, p=.001, respectively). CM risk factors andMS are common in children with hepatosteatosis. The presence and grade ofhepatosteatosis on ultrasound can be used as surrogate markers of MS andCM risk in children.
___
1. McGill HC Jr, McMahan CA, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 2008; 117: 1216- 1217.
2. Tanrikulu MA, Agirbasli M, Berenson G. Primordial prevention of cardiometabolic risk in childhood. Adv Exp Med Biol 2017; 956: 489-496.
3. Agirbasli M, Tanrikulu AM, Berenson GS. Metabolic syndrome: bridging the gap from childhood to adulthood. Cardiovasc Ther 2016; 34: 30-36.
4. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007; 120: 340-345.
5. Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr 2017; 6: 397- 407.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III. JAMA 2001; 285: 2486-2497.
7. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-443.
8. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059- 1062.
9. Agirbasli M, Adabag S, Ciliv G. Secular trends of blood pressure, body mass index, lipids and fasting glucose among children and adolescents in Turkey. Clin Obes 2011; 1: 161-167.
10. Fu JF, Shi HB, Liu LR, et al. Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children? World J Gastroenterol 2011; 17: 735-742.
11. Di Sessa A, Umano GR, Miraglia Del Giudice E. The association between non-alcoholic fatty liver disease and cardiovascular risk in children. Children (Basel) 2017; 4: E57.
12. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005; 50: 171-180.
13. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of nonalcoholic steatohepatitis. Clin Liver Dis 2007; 11: 37-54.
14. Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 2013; 58: 1007-1019.
15. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090.
16. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
17. Wilson SR, Withers CE. The liver. In: Rumack CM, Wilson SR, Charboneau JW, Johnson JAM (eds). Diagnostic Ultrasound (3rd ed). St Louis, MO: CV Mosby Co; 2005: 77-146.
18. Genuth S, Alberti KG, Bennett P, et al; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160- 3167.
19. Hatipoğlu N, Kurtoğlu S, Oztürk A, Mazıcıoğlu MM. The weight and height percentiles in 6-18 year old children in Kayseri and comparison with Istanbul data. J Clin Res Pediatr Endocrinol 2009; 1: 129-135.
20. Rosner B, Prineas RJ, Loggie JMH, Daniels SR. Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States. J Pediatr 1993; 123: 871-886.
21. NGHS Coordinating Center. NHLBI Growth and Health Study (NGHS) data monitoring report. Baltimore: Maryland Medical Research, 1998.
22. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic syndrome in Turkish children and adolescents. Metabolism 2006; 55: 1002-1006.
23. Berenson GS, Agirbasli M, Nguyen QM, Chen W, Srinivasan SR. Glycemic status, metabolic syndrome, and cardiovascular risk in children. Med Clin North Am 2011; 95: 409-417.
24. Agirbasli M, Agaoglu NB, Ergonul O, et al. Comparison of anthropometric indices in predicting metabolic syndrome components in children. Metab Syndr Relat Disord 2011; 9: 453-459.
25. Borici S, Agaoglu NB, Baykan OA, Agirbasli M. Blood pressure and anthropometric measurements in Albanian versus Turkish children and adolescents. Acta Cardiol 2009; 64: 747-754.
26. Elmaoğulları S, Tepe D, Uçaktürk SA, Karaca KF, Demirel F. Prevalence of dyslipidemia and associated factors in obese children and adolescents. J Clin Res Pediatr Endocrinol 2015; 7: 228-234.
27. Torun E, Aydın S, Gökçe S, Özgen IT, Donmez T, Cesur Y. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease. Turk J Gastroenterol 2014; 25(Suppl 1): 92-98.
28. Seo JY, Kim JH. Validation of surrogate markers for metabolic syndrome and cardiometabolic risk factor clustering in children and adolescents: a nationwide population-based study. PLoS One 2017; 12: e0186050.
29. Agirbasli M, Agaoglu NB, Orak N, et al. Sex hormones and metabolic syndrome in children and adolescents. Metabolism 2009; 58: 1256-1262.